Suppr超能文献

佛蒙特州受控物质滥用、转移、储存、处置、监测及法律问题

Vermont Controlled Substance Abuse, Diversion, Storage, Disposal, Monitoring, and Legal Issues

作者信息

Dydyk Alexander M., Sizemore Daniel C., Trachsel Lindsay A., Conermann Till, Porter Burdett R.

机构信息

Abrazo Central Campus

WVU Medicine

Abstract

Opioid abuse is a significant problem in the United States. Over one-quarter of United States citizens suffer from chronic pain. It is among the most common complaints in outpatient clinics and emergency departments. The failure to manage chronic pain, as well as the possible complication of opioid dependence related to treatment, can result in significant morbidity and mortality. One in 5 patient complaints in an outpatient clinic is related to pain, with over half of all patients seeing their primary care provider for 1 pain complaint or another. It is paramount that providers have a firm grasp on the management of patients with chronic pain. The United States spends well over 100 billion dollars annually on healthcare costs related to pain management and opioid dependence. Pain-related expenses exceed the costs of cancer, diabetes, and heart disease combined. How a patient's chronic pain gets managed can have profound and long-lasting effects on a patient's quality of life. The International Association for the Study of Pain defines chronic pain as any pain lasting longer than 3 months. There are multiple sources of chronic pain. Combination therapy for pain includes both pharmacological therapies and nonpharmacological treatment options. There is a more significant reduction in pain with combination therapy compared to a single treatment alone. Escalation of pharmacological therapy is done using a stepwise approach. Comorbid depression and anxiety are widespread in patients with chronic pain. Patients with chronic pain are also at increased risk for suicide. Chronic pain can impact every facet of a patient's life. Thus, learning to diagnose and appropriately manage patients experiencing chronic pain is critical. Unfortunately, studies have revealed an inherent lack of education regarding pain management in most medical schools and training programs. The Association of American Medical Colleges recognized the problem and has encouraged schools to commit to opioid-related education and training by incorporating the Centers for Disease Control and Prevention guidelines for prescribing opioids for chronic pain into the medical school curriculum. Appropriate opioid prescribing includes prescribing sufficient opioid medication through regular assessment, treatment planning, and monitoring to provide effective pain control while avoiding addiction, abuse, overdose, diversion, and misuse. To be successful, clinicians must understand appropriate opioid prescribing, assessment, the potential for abuse and addiction, and potential psychological problems. Inappropriate opioid prescribing typically involves not prescribing, underprescribing, overprescribing, or continuing to prescribe opioids when they are no longer effective. The American Society of Addiction Medicine describes addiction as a treatable chronic disease that involves environmental pressures, genetics, an individual's life experiences, and interactions among brain circuits.Individuals who become addicted to opioids or other medications often engage in behaviors that become compulsive and result in dangerous consequences. The American Society of Addiction Medicines notes that while the following should not be used as diagnostic criteria due to variability among addicted individuals, they identify 5 characteristics of addiction: 1. Craving for drug or positive reward. 2. Dysfunctional emotional response. 3. Failure to recognize significant problems affecting behavior and relationships. 4. Inability to consistently abstain. 5. Impairment in control of behavior. Unfortunately, most health providers' understanding of addiction is often confusing, inaccurate, and inconsistent due to the broad range of perspectives of those dealing with patients suffering from addiction. While a knowledge gap exists among healthcare providers, it is equally prevalent in politicians writing laws and law enforcement attempting to enforce them. Payers are responsible for the expenses associated with evaluating and treating addiction. Persistent lack of education and the use of obsolete terminology continue to contribute to a societal lack of understanding for effectively dealing with the challenges of addiction. In the past, the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders defined "addiction," "substance abuse," and "substance dependence" separately. The result was provider confusion contributed to the under-treatment of pain. Over time, the manual has eliminated these terms and now uses "substance use disorder," ranging from mild to severe. Unfortunately, numerous pain management challenges exist, such as underprescribing and overprescribing opioids. The concerns are particularly prominent in patients with chronic pain and have resulted in patients suffering from inadequately treated pain. At the same time, there has been a development of concomitant opioid abuse, addiction, diversion, and overdose. As a result, providers are often negatively influenced and fail to deliver appropriate, effective, and safe opioids to patients with chronic pain. Providers have, in the past, been poorly trained and ill-informed in their opioid prescribing. To make the challenges even worse, chronic pain patients often develop opioid tolerance and significant psychological, behavioral, and emotional problems, including anxiety and depression related to under or overprescribing opioids.  Clinicians who prescribe opioids face challenges that involve medical negligence in either failure to provide adequate pain control or risk of licensure or even criminal charges if it is perceived they are engaged in drug diversion or misuse. All providers that prescribe opioids need additional education and training to provide the best patient outcomes and avoid the social and legal entanglements associated with over and underprescribing opioids. There are substantial knowledge gaps around appropriate and inappropriate opioid prescribing, including deficits in understanding current research, legislation, and appropriate prescribing practices. Providers often have knowledge deficits that include: Understanding of addiction. At-risk opioid addiction populations. Prescription vs. non-prescription opioid addiction. The belief that addiction and dependence on opioids are synonymous. The belief that opioid addiction is a psychological problem instead related to a chronic painful disease. With a long history of misunderstanding, poor society, provider education, and inconsistent laws, prescribing opioids has resulted in significant societal challenges that are only resolved with significant education and training.

摘要

阿片类药物滥用在美国是一个严重问题。超过四分之一的美国公民患有慢性疼痛。这是门诊诊所和急诊科最常见的病症之一。慢性疼痛管理不善以及与治疗相关的阿片类药物依赖可能引发的并发症,会导致严重的发病和死亡。门诊诊所中五分之一的患者投诉与疼痛有关,超过半数的患者因疼痛问题就诊于初级医疗服务提供者。医疗服务提供者必须扎实掌握慢性疼痛患者的管理方法,这至关重要。美国每年在与疼痛管理和阿片类药物依赖相关的医疗费用上支出超过1000亿美元。与疼痛相关的费用超过了癌症、糖尿病和心脏病费用的总和。患者慢性疼痛的管理方式会对其生活质量产生深远而持久的影响。国际疼痛研究协会将慢性疼痛定义为持续超过3个月的任何疼痛。慢性疼痛有多种来源。疼痛的联合治疗包括药物治疗和非药物治疗选项。与单一治疗相比,联合治疗能更显著地减轻疼痛。药物治疗的升级采用逐步推进的方法。慢性疼痛患者中,共病的抑郁和焦虑很普遍。慢性疼痛患者的自杀风险也会增加。慢性疼痛会影响患者生活的方方面面。因此,学会诊断并妥善管理慢性疼痛患者至关重要。不幸的是,研究表明,大多数医学院校和培训项目在疼痛管理方面存在内在的教育缺失。美国医学院协会认识到了这个问题,并鼓励学校将疾病控制与预防中心关于慢性疼痛阿片类药物处方的指南纳入医学院课程,致力于与阿片类药物相关的教育和培训。恰当的阿片类药物处方包括通过定期评估、治疗规划和监测,开具足够的阿片类药物,以有效控制疼痛,同时避免成瘾、滥用、过量、转移和误用。要取得成功,临床医生必须了解恰当的阿片类药物处方、评估、滥用和成瘾的可能性以及潜在的心理问题。不恰当的阿片类药物处方通常包括不开具、开具不足、开具过量,或者在阿片类药物不再有效时继续开具。美国成瘾医学协会将成瘾描述为一种可治疗的慢性疾病,涉及环境压力、遗传因素、个人生活经历以及脑回路之间的相互作用。对阿片类药物或其他药物成瘾的人常常会出现强迫性行为,并导致危险后果。美国成瘾医学协会指出,虽然由于成瘾个体之间存在差异,以下内容不应作为诊断标准,但它们确定了成瘾的5个特征:1. 对药物或积极奖励的渴望。2. 功能失调的情绪反应。3. 未能认识到影响行为和人际关系的重大问题。4. 无法持续戒除。5. 行为控制受损。不幸的是,由于处理成瘾患者的人员观点广泛,大多数医疗服务提供者对成瘾的理解往往混乱、不准确且不一致。虽然医疗服务提供者之间存在知识差距,但在制定法律的政治家和试图执行法律执行人员中同样普遍存在。支付方负责与成瘾评估和治疗相关的费用。持续缺乏教育以及使用过时的术语,继续导致社会对有效应对成瘾挑战缺乏理解。过去,美国精神病学协会的《精神疾病诊断与统计手册》分别定义了“成瘾”“物质滥用”和“物质依赖”。结果导致医疗服务提供者困惑,进而造成疼痛治疗不足。随着时间推移,该手册已删除这些术语,现在使用“物质使用障碍”,范围从轻度到重度。不幸的是,存在许多疼痛管理挑战,如阿片类药物开具不足和开具过量。这些问题在慢性疼痛患者中尤为突出,导致患者疼痛治疗不充分。与此同时,出现了阿片类药物滥用、成瘾、转移和过量使用的情况。因此,医疗服务提供者常常受到负面影响,无法为慢性疼痛患者提供恰当、有效和安全的阿片类药物。过去,医疗服务提供者在阿片类药物处方方面培训不足且信息匮乏。更糟糕的是,慢性疼痛患者常常会产生阿片类药物耐受性以及严重的心理、行为和情绪问题,包括与阿片类药物开具不足或过量相关的焦虑和抑郁。开具阿片类药物的临床医生面临诸多挑战,包括因未能提供充分的疼痛控制而导致医疗过失,或者如果被认为参与药物转移或滥用,可能面临执照吊销甚至刑事指控。所有开具阿片类药物的医疗服务提供者都需要额外的教育和培训,以实现最佳的患者治疗效果,并避免与阿片类药物开具过量和不足相关的社会和法律纠纷。在恰当和不恰当的阿片类药物处方方面存在大量知识空白,包括对当前研究、立法和恰当处方实践的理解不足。医疗服务提供者常常存在知识缺陷,包括:对成瘾的理解。阿片类药物成瘾的高危人群。处方与非处方阿片类药物成瘾。认为成瘾和对阿片类药物的依赖是同义词。认为阿片类药物成瘾是心理问题而非与慢性疼痛疾病相关。由于长期存在误解、社会认知差、医疗服务提供者教育不足以及法律不一致,阿片类药物处方引发了重大的社会挑战,只有通过大量的教育和培训才能解决。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验